Browsing Health Sciences Conference Papers by Subject "3211 Oncology and carcinogenesis"
Now showing items 1-5 of 5
-
Developed and validated script for 18F – PSMA -1007 Synthesis in IBA – Synthera version-01
(2022-06)Prostate cancer is the most frequent cancer among males around the world. According to the American Cancer Society's website, one out of every nine males is likely to be diagnosed with prostate cancer [1]. It is the world's ... -
FAP still more question to be answered: A review-based analysis
(Society of Nuclear Medicine and Molecular Imaging, 2023-08-28)Over ninety percent of epithelial malignancies have elevated levels of fibroblast activation protein (FAP), a type II transmembrane serine protease that is closely associated with tumour invasion, metastasis, and prognosis. ... -
A first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate cancer
(2021-11)Prostate cancer that has spread beyond the prostate gland and is resistant to castration is a deadly disease that poses a threat to men's health. The current standard of care for metastatic prostate cancer is hormonal ... -
A first NZ study looked at the role of Lutetium-177-PSMA I & T in the progression of mCRPC
(2022-07-23)OBJECTIVES To assess the efficacy of Lutetium-177-PSMA-I&T therapy to palliate end stage mCRPC To review tolerability and impact on QOL of Lutetium-177- PSMA-I&T therapy -
Yttrium-90 based bremsstrahlung Imaging with a solid state detector gamma camera: A first imaging experience with GE-NM CT 850
(Society of Nuclear Medicine and Molecular Imaging, 2023-08-28)INTRODUCTION Yttrium-90 (Y90) is an efficient therapeutic radioisotope for tumour treatment due to its high-energy beta rays. However, due to the vast energy spectra of Y-90, its always been challenging for Y-90 ...